Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl)

Journal of Fluorescence

Volumn 21, Issue 1, 2011, Pages 105-112

  Walsh, M ^a   Belal, F ^a   El Enany, Nahed ^a   Elmansi, H ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

4 chloro 7 nitobenzo 2 oxa 1,3 diazole (NBD Cl); Dosage forms; Paroxetine HCl; Spectrofluorimetry

Indexed keywords

4-CHLORO-7-NITOBENZO -2-OXA-1,3-DIAZOLE (NBD-CL); ALKALINE MEDIUM; COUPLING REACTION; DERIVATIZATIONS; DOSAGE FORMS; MEAN PERCENTAGE; PAROXETINE; REACTION PATHWAYS; REFERENCE METHOD; SPECTROFLUORIMETRIC DETERMINATION; SPECTROFLUORIMETRIC METHODS; SPECTROFLUORIMETRY;

FLUORESCENCE;

4 CHLORO 7 NITROBENZOFURAZAN; ANTIDEPRESSANT AGENT; DRUG; PAROXETINE;

ARTICLE; CALIBRATION; CHEMISTRY; LIMIT OF DETECTION; METHODOLOGY; PH; REPRODUCIBILITY; SPECTROFLUOROMETRY; STANDARD; TABLET; VALIDATION STUDY;

4-CHLORO-7-NITROBENZOFURAZAN; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CALIBRATION; HYDROGEN-ION CONCENTRATION; LIMIT OF DETECTION; PAROXETINE; PHARMACEUTICAL PREPARATIONS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; TABLETS;

EID: 79951508993     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-010-0693-2     Document Type: Article

References (29)

1. The British Pharmacopoeia. The stationary office: London, (2007), Electronic version
2. Sweetman SC (ed) (2009) Martindale: the complete drug reference. Pharmaceutical, London, Electronic version
3. IA Zainaghi VL Lanchote RHC Queiroz 2003 Determination of paroxetine in geriatric depression by high performance liquid chromatography Pharmacol Res 48 217 221 1:CAS:528:DC%2BD3sXksVGksL4%3D 10.1016/S1043-6618(03)00098-7 12798675 (Pubitemid 36683171)
4. Z Zhu L Neirinck 2002 High-performance liquid chromatography-mass spectrometry method for the determination of paroxetine in human plasma J Chromatogr B 780 295 300 1:CAS:528:DC%2BD38XptlansrY%3D 10.1016/S1570-0232(02) 00537-8 (Pubitemid 35223565)
5. P Massaroti NM Cassiano LF Durate 2005 Validation of a selective method for determination of paroxetine in human plasma by LC-MS/MS J Pharm Pharm Sci 8 340 347 1:CAS:528:DC%2BD2MXhtFWls7zN 16124946 (Pubitemid 41519148)
6. OH Jheee HK Seo MH Lee 2007 Determination of paroxetine in plasma by liquid chromatography coupled to tandem mass spectrometry for pharmacokinetic and bioequivalence studie Arzeneimittel-Forschung 57 455 461
7. British Pharmacopoeia (2003) The Stationary Office, London, UK
8. HPA Nouws C Delerue-Matos AA Barros JA Rodrigues 2006 Electroanalytical determination of paroxetine in pharmaceuticals, J Pharm Biomed Anal 42 341 346 1:CAS:528:DC%2BD28XpsVWlurg%3D 10.1016/j.jpba.2006.04.015 16765014 (Pubitemid 44335829)
9. N Erk J Biryol 2003 Voltammetric and HPLC techniques for the determination of paroxetine hydrochloride Pharmazie 58 699 704 1:CAS:528:DC%2BD3sXos1Gmu78%3D 14609280 (Pubitemid 37328398)
10. CB Eap G Bouchoux M Amey N Cochard L Savary P Baumann 1998 Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry J Chromatogr Sci 36 365 371 1:CAS:528:DyaK1cXksFyit74%3D 9679303 (Pubitemid 128659155)
11. JL Hans W Werner F Günter 2002 Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionization gas chromatography-mass spectrometry J Chromatogr B 779 353 357 10.1016/S1570-0232(02)00378-1 (Pubitemid 35279463)
12. L Chien SG Emily HK Sidney N Alan TC Ronald BB Glen 2000 Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection J Chromatogr B 749 275 279 10.1016/S0378-4347(00) 00389-3
13. L Labat M Deveaux P Dallet JP Dubost 2002 Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography J Chromatogr B 773 17 23 1:CAS:528:DC%2BD38XltVGltLk%3D 10.1016/S1570-0232(01)00623-7 (Pubitemid 34518266)
14. A Onal SE Kepekçi A Oztunç 2005 Spectrophotometric methods for the determination of the antidepressant drug paroxetine hydrochloride in tablets J AOAC Int 88 490 495 15859076 (Pubitemid 40479405)
15. IA Darwish IH Refaat 2006 Spectrophotometric analysis of selective serotonin reuptake inhibitors based on formation of charge-transfer complexes with tetracyanoquinodimethane and chloranilic acid J AOAC Int 89 326 333 1:CAS:528:DC%2BD28XjsVGksbc%3D 16640280 (Pubitemid 46002962)
16. IA Darwish 2005 Development and validation of spectrophotometric methods of fluoxetine, sertraline and paroxetine in pharmaceutical dosage forms J AOAC Int 88 38 45 1:CAS:528:DC%2BD2MXhtlaqur8%3D 15759724 (Pubitemid 40207013)
17. Darwish IA, Abdine H, Amer S, Al-Rayes L (2009) Simple spectrophotometric method for determination of paroxetine in tablets using 1,2-Naphthoquinone-4- sulphonate as a chromogenic reagent. International Journal of Analytical Chemistry, vol. 2009: ID 237601
18. EA Taha NN Salama L Fattah 2006 Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1, 3-diazole(NBD-Cl) Chem Pharm Bull (Tokyo) 54 653 658 1:CAS:528:DC%2BD28Xmt1ehs70%3D 10.1248/cpb.54.653
19. N El-Enany D El-Sherbiny F Belal 2007 Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma Chem Pharm Bull (Tokyo) 55 1662 1670 1:CAS:528:DC%2BD1cXht1ymu70%3D 10.1248/cpb.55.1662 (Pubitemid 350232535)
20. HM Saleh MM El-Henawee GH Ragab SS El-Hay 2007 Utility of NBD-Cl for the spectrophotometric determination of some skeletal muscle relaxant and antihistaminic drugs Spectrochim Acta 67 1284 1289 10.1016/j.saa.2006.09.039 (Pubitemid 47017771)
21. RO Olojo RH Xia JJ Abramson 2005 Spectrophotometric and fluorometric assay of superoxide ion using 4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole Anal Biochem 339 338 344 1:CAS:528:DC%2BD2MXis1Gktrg%3D 10.1016/j.ab.2005.01.032 15797575 (Pubitemid 40395292)
22. H Miyano T Toyo'oka H Miyano 1985 Anal Chim Acta 170 81 1:CAS:528:DyaL2MXks1Ortrs%3D 10.1016/S0003-2670(00)81728-6
23. Guidance for Industry; Q2B of Analytical Procedures: Methodology; International Conference on Hormonization (ICH), November (1996). http://www.fda.gov/eder/guidance/1320fnl.pdf (accessed September 1, 2004)
24. Miller JN, Miller JC (2005) Statistics and chemometrics for analytical chemistry, 5th edn. Prentice Hall, England, 256
25. Rose (2006) J Advanced Physico-Chemical Experiments. Pitman, London, 1964
26. N El-Enany F Belal M Rizk 2006 Kinetic Spectrophotometric Determination of Isoxsuprine in Dosage Forms Through Derivatization with 4-chloro-7- nitrobenzo-2-oxa-1, 3- diazole (NBD-Cl) Sci Pharm 74 99 119 1:CAS:528: DC%2BD28XhtlWmsLvF 10.3797/scipharm.2006.74.99 (Pubitemid 44701574)
27. MR Crampton J Delaney LC Rabbitt 1999 Unusual reaction of 4-nitrobenzofurazan with amines J Chem Soc Perkin Trans 2 2473
28. G Moutires J Pinson F Terrier R Goumont 2001 Chem Eur J 7 1712 10.1002/1521-3765(20010417)7:8<1712::AID-CHEM17120>3.0.CO;2-G (Pubitemid 32335866)
29. M Makosza J Winiarski 1987 Acc Chem Res 20 282 289 1:CAS:528: DyaL2sXkslOgtrg%3D 10.1021/ar00140a003